Protamine is an FDA-approved compound with a documented safety profile that facilitates efficient plasmid condensation for gene delivery by various types of cationic liposomes. It also improves adenoviral vector-mediated gene transfer as a transfection accelerator. However, there is no consensus as to the mechanism of protamine on gene delivery into cells. To analyze the uptake and subcellular distribution, plasmid and protamine were labeled with FITC and Texas-Red, respectively. Although the uptake of FITC-labeled plasmid/protamine complexes into the cells was the same as that of free FITC-labeled plasmid in HeLa, SOJ and A549 cells, they improved the transfection efficiency by several orders of magnitude. Moreover, we found that protamine derived from different sources (salmon, herring and trout sperm) had different transfection efficiencies; however, the gene transfer efficiency with protamine was lower than with optimized poly(L-lysine) and DEAE-Dextran. There were likely two main reasons: firstly, the uptake of plasmid mediated by protamine was complete within the first 10min because the particle size increased as time passed, and secondly, the plasmid/protamine complexes were not released from endosomal membrane. These results indicate that as a transfection accelerator from an appropriate protamine source, with controlled particle size and facile release from endosomes would lead to successful gene delivery with protamine.
Mahato, R.I. , Rolland, A. and Tomlinson, E. (1997). Cationic Lipid-based Gene Delivery Systems: Pharmaceutical Perspectives , Pharm. Res., 14: 853–859 .
2.
El Aneed, A. (2004). An Overview of Current Delivery Systems in Cancer Gene Therapy , J. Control Release, 94: 1–14 .
3.
Helbling-Leclerc, A. , Scherman, D. and Wils, P. (1999). Cellular Uptake of Cationic Lipid/DNA Complexes by Cultured Myoblasts and Myotubes , Biochim. Biophys. Acta, 1418: 165–175 .
4.
Xu, Y. , Hui, S.W. , Frederik, P. and Szoka Jr, F.C. (1999). Physicochemical Characterization and Purification of Cationic Lipoplexes , Biophys. J., 77: 341–353 .
5.
Zeisig, R. , Arndt, D. , Stahn, R. and Fichtner, I. (1998). Physical Properties and Pharmacological Activity In Vitro and In Vivo of Optimised Liposomes Prepared from a New Cancerostatic Alkylphospholipid , Biochim. Biophys. Acta, 1414: 238–248 .
6.
Ferrari, S. , Pettenazzo, A. , Garbati, N. , Zacchello, F. , Beh, J.P. and Scarpa, M. (1999). Polyethylenimine Shows Properties of Interest for Cystic Fibrosis Gene Therapy , Biochim. Biophys. Acta, 1447: 219–225 .
7.
Sato, T. , Ishii, T. and Okahata, Y. (2001). In Vitro Gene Delivery Mediated by Chitosan. Effect of pH, Serum, and Molecular Mass of Chitosan on the Transfection Efficiency , Biomaterials, 22: 2075–2080 .
8.
Bettinger, T. , Remy, J.S. and Erbacher, P. (1999). Size Reduction of Galactosylated PEI/DNA Complexes Improves Lectin-mediated Gene Transfer into Hepatocytes , Bioconjug. Chem., 10: 558–561 .
9.
Laurent, N. , Wattiaux-De Coninck, S. , Mihaylova, E. , Leontieva, E. , Warnier-Pirotte, M.T. , Wattiaux, R. and Jadot, M. (1999). Uptake by Rat Liver and Intracellular Fate of Plasmid DNA Complexed with Poly-L-lysine or Poly-D-lysine , Febs Lett., 443: 61–65 .
10.
Ishii, T. , Okahata, Y. and Sato, T. (2001). Mechanism of Cell Transfection with Plasmid/Chitosan Complexes , Biochim. Biophys. Acta, 1514: 51–64 .
11.
Son, K.K. , Tkach, D. and Patel, D.H. (2000). Zeta Potential of Transfection Complexes Formed in Serum-Free Medium can Predict In Vitro Gene Transfer Efficiency of Transfection Reagent , Biochim. Biophys. Acta, 1468: 11–14 .
12.
El Aneed, A. (2004). An Overview of Current Delivery Systems in Cancer Gene Therapy , J. Control Release, 94: 1–14 .
13.
Sorgi, F.L. , Bhattacharya, S. and Huang, L. (1997). Protamine Sulfate Enhances Lipid-mediated Gene Transfer , Gene Ther., 4: 961–968 .
14.
Li, S. , Rizzo, M.A. , Bhattacharya, S. and Huang, L. (1998). Characterization of Cationic Lipid-protamine-DNA (LPD) Complexes for Intravenous Gene Delivery , Gene Ther., 5: 930–937 .
15.
Li, S. and Huang. L. (1997). In Vivo Gene Transfer Via Intravenous Administration of Cationic Lipid-protamine-DNA (LPD) Complexes , Gene Therapy, 4: 891–900 .
16.
Sun, X. and Zhang, Z. (2004). Optimizing the Novel Formulation of Lipo-some-polycation-DNA Complexes (LPD) by Central Composite Design , Arch. Pharm. Res., 27: 797–805 .
17.
Clark, P.R. , Stopeck, A.T. , Brailey, J.L. , Wang, Q. , McArthur, J. , Finer, M.H. and Hersh, E. M. (1999). Polycations and Cationic Lipids Enhance Adenovirus Transduction and Transgene Expression in Tumor Cells , Cancer Gene Ther., 6: 437–446 .
18.
Mizuarai, S. , Ono, K. , You, J. , Kamihira, M. and Iijima, S. (2001). Prota-mine-modified DDAB Lipid Vesicles Promote Gene Transfer in the Presence of Serum , J. Biochem. (Tokyo), 129: 125–132 .
19.
Sun, X. , Hai, L. , Wu, Y. , Hu, H.Y. and Zhang, Z.R. (2005). Targeted Gene Delivery to Hepatoma Cells Using Galactosylated Liposome-polycation-DNA Complexes (LPD) , J. Drug Target, 13: 121–128 .
20.
Tan, Y. , Li, S. , Pitt, B.R. and Huang, L. (1999). The Inhibitory Role of CPG Immunostimulatory Motifs in Cationic Lipid Vector-mediated Trans-gene Expression In Vivo , Human Gene Ther., 10: 2153–2161 .
21.
Li, S. , Rizzo, M.A. , Bhattacharya, S. and Huang, L. (1998). Characterization of Cationic Lipid-protamine-DNA (LPD) Complexes for Intravenous Gene Delivery , Gene Ther., 5: 930–937 .
22.
Sun, X. and Zhang, Z. (2004). Optimizing the Novel Formulation of Lipo-some-polycation-DNA Complexes (LPD) by Central Composite Design , Arch. Pharm. Res., 27: 797–805 .
23.
Clark, P.R. , Stopeck, A.T. , Brailey, J.L. , Wang, Q. , McArthur, J. , Finer, M.H. and Hersh, E.M. (1999). Polycations and Cationic Lipids Enhance Adenovirus Transduction and Transgene Expression in Tumor Cells , Cancer Gene Ther., 6: 437–446 .
24.
Mizuarai, S. , Ono, K. , You, J. , Kamihira, M. and Iijima, S. (2001). Prota-mine-modified DDAB Lipid Vesicles Promote Gene Transfer in the Presence of Serum , J. Biochem. (Tokyo), 129: 125–132 .
25.
Sun, X. , Hai, L. , Wu, Y. , Hu, H.Y. and Zhang, Z.R. (2005). Targeted Gene Delivery to Hepatoma Cells Using Galactosylated Liposome-polycation-DNA Complexes (LPD) , J. Drug Target, 13: 121–128 .
26.
Clark, P.R. , Stopeck, A.T. , Brailey, J.L. , Wang, Q. , McArthur, J. , Finer, M.H. and Hersh, E.M. (1999). Polycations and Cationic Lipids Enhance Adenovirus Transduction and Transgene Expression in Tumor Cells , Cancer Gene Ther., 6: 437–446 .
27.
Badran, S. , Schachtner, S.K. , Baldwin, H.S. and Rome, J.J. (2000). Optimization of Adenoviral Vector-mediated Gene Transfer to Pulmonary Arteries in Newborn Swine , Hum. Gene Ther., 11: 1113–1121 .
28.
Lanuti, M. , El Kouri, C. , Force, S.D. , Chang, M.Y. , Amin, K. , Xu, K. , Blair, I.A. , Kaiser, L.R. and Albelda, S.M. (1999). Use of Protamine to Augment Adenovirus-mediated Cancer Gene Therapy , Gene Ther., 6: 1600–1610 .
29.
Sabelnikov, A.G. , Ditjatkin, S.J. and Iljashenko, B.N. (1973). About the Role of Protamine in Transfection , Biochimica Et Biophysica Acta, 299: 492–495 .
30.
Wienhues, U. , Hosokawa, K. , Hoveler, A. , Siegmann, B. and Doerfler, W. (1987). A Novel Method for Transfection and Expression of Reconstituted DNA-Protein Complexes in Eukaryotic Cells , DNA, 6: 81–89 .
31.
Ishii, T. , Okahata, Y. and Sato, T. (2000). Facial Preparation of a Fluorescence-labeled Plasmid , Chemistry Letter, 2000: 386–387 .
32.
Futaki, S. , Suzuki, T. , Ohashi, W. , Yagami, T. , Tanaka, S. , Ueda, K. and Sugiura, Y. (2001). Arginine-rich Peptides. An Abundant Source of Membrane-permeable Peptides Having Potential as Carriers for Intracellular Protein Delivery , J. Biol. Chem., 276: 5836–5840 .
33.
El Aneed, A. (2004). An Overview of Current Delivery Systems in Cancer Gene Therapy , J. Control Release, 94: 1–14 .
34.
Ishii, T. , Okahata, Y. and Sato, T. (2001). Mechanism of Cell Transfection with Plasmid/Chitosan Complexes , Biochim. Biophys. Acta, 1514: 51–64 .
35.
Sato, T. , Ishii, T. and Okahata, Y. (2001). In Vitro Gene Delivery Mediated by Chitosan. Effect of pH, Serum, and Molecular Mass of Chitosan on the Transfection Efficiency , Biomaterials, 22: 2075–2080 .
36.
Bettinger, T. , Remy, J.S. and Erbacher, P. (1999). Size Reduction of Galactosylated PEI/DNA Complexes Improves Lectin-mediated Gene Transfer into Hepatocytes , Bioconjug. Chem., 10: 558–561 .
37.
Pari, G.S. and Xu, Y. (2004). Gene Transfer into Mammalian Cells Using Calcium Phosphate and DEAE-Dextran , Methods Mol. Biol., 245: 25–32 .
38.
El Ouahabi, A. , Thiry, M. , Pector, V. , Fuks, R. , Ruysschaert, J.M. and Vandenbranden, M. (1997). The Role of Endosome Destabilizing Activity in the Gene Transfer Process Mediated by Cationic Lipids , Febs Lett., 414: 187–192 .
39.
Zabner, J. , Fasbender, A.J. , Moninger, T. , Poellinger, K.A. and Welsh, M.J. (1995). Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid , J. Biol. Chem., 270: 18997–19007 .
40.
Koltover, I. , Salditt, T. , Radler, J.O. and Safinya, C.R. (1998). An Inverted Hexagonal Phase of Cationic Liposome-DNA Complexes Related to DNA Release and Delivery , Science, 281: 78–81 .
41.
Zhou, X. and Huang, L. (1994). DNA Transfection Mediated by Cationic Liposomes Containing Lipopolylysine: Characterization and Mechanism of Action , Biochim. Biophys. Acta, 1189: 195–203 .
42.
Felgner, P.L. , Gadek, T.R. , Holm, M. , Roman, R. , Chan, H.W. , Wenz, M. , Northop, J.P. , Ringold, G.M. and Danielsen, M. (1987). Lipofection: A Highly Efficient, Lipid-mediated DNA-Transfection Procedure , Proc. Natl. Acad. Sci. U.S.A., 84: 7413–7417 .
Kabanov, A.V. (1999). Taking Polycation Gene Delivery Systems from In Vitro to In Vivo , Pharm. Sci. Technol. Today, 2: 365–372 .
45.
Foster, K.A. , Yazdanian, M. and Audus, K.L. (2001). Microparticulate Uptake Mechanisms of In Vitro Cell Culture Models of the Respiratory Epithelium , J. Pharm. Pharmacol., 53: 57–66 .
46.
Beh, J.P. (1994). Gene Transfer with Synthetic Cationic Amphiphiles: Prospects for Gene Therapy , Bioconjug. Chem., 5: 382–389 .
47.
Boussif, O. , Lezoualc'h, F. , Zanta, M.A. , Mergny, M.D. , Scherman, D. , Demeneix, B. and Beh, J.P. (1995). A Versatile Vector for Gene and Oligonucleotide Transfer into Cells in Culture and In Vivo: Polyethylenimine , Proc. Natl. Acad. Sci. U.S.A., 92: 7297–7301 .
48.
Zabner, J. , Fasbender, A.J. , Moninger, T. , Poellinger, K.A. and Welsh, M.J. (1995). Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid , J. Biol. Chem., 270: 18997–19007 .
49.
Dingwall, C. and Laskey, R.A. (1991). Nuclear Targeting Sequences – a Consensus? , Trends Biochem. Sci., 16: 478–481 .
50.
Moir, R.D. and Dixon, G.H. (1988). Characterization of a Protamine Gene from the Chum Salmon (Oncorhynchus Keta) , J. Mol. Evol., 27: 8–16 .
51.
Ando, T. , Yamasaki, M. and Suzuki, K. (1973). Protamines. Isolation, Characterization, Structure and Function , Mol. Biol., Biochem. and Biophys., 12: 1–114 .
52.
Masuda, T. , Akita, H. and Harashima, H. (2005). Evaluation of Nuclear Transfer and Transcription of Plasmid DNA Condensed with Protamine by Microinjection: the Use of a Nuclear Transfer Score , Febs Lett., 579: 2143–2148 .
53.
You, J. , Kamihira, M. and Iijima, S. (1999). Enhancement of Transfection Efficiency by Protamine in DDAB Lipid Vesicle-mediated Gene Transfer , J. Biochem. (Tokyo), 125: 1160–1167 .
54.
Xu, Y. , Hui, S.W. , Frederik, P. and Szoka Jr, F.C. (1999). Physicochemical Characterization and Purification of Cationic Lipoplexes , Biophys. J., 77: 341–353 .
55.
Li, S. , Rizzo, M.A. , Bhattacharya, S. and Huang, L. (1998). Characterization of Cationic Lipid-protamine-DNA (LPD) Complexes for Intravenous Gene Delivery , Gene Ther., 5: 930–937 .
56.
Sorgi, F.L. , Bhattacharya, S. and Huang, L. (1997). Protamine Sulfate Enhances Lipid-mediated Gene Transfer , Gene Ther., 4: 961–968 .
57.
Vitiello, L. , Chonn, A. , Wasserman, J.D. , Duff, C. and Worton, R.G. (1996). Condensation of Plasmid DNA with Polylysine Improves Liposome-mediated Gene Transfer into Established and Primary Muscle Cells , Gene Ther., 3: 396–404 .
